Iain H. McKillop - Publications

Affiliations: 
Biology (PhD) University of North Carolina, Charlotte, Charlotte, NC, United States 
Area:
Cell Biology, Oncology, Biochemistry

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Osna NA, Tikhanovich I, Ortega-Ribera M, Mueller S, Zheng C, Mueller J, Li S, Sakane S, Weber RCG, Kim HY, Lee W, Ganguly S, Kimura Y, Liu X, Dhar D, ... ... McKillop IH, et al. Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression. Biomolecules. 14. PMID 38672422 DOI: 10.3390/biom14040404  0.312
2021 Benbow JH, Marrero E, McGee RM, Brandon-Warner E, Attal N, Feilen NA, Culberson CR, McKillop IH, Schrum LW. HEPATIC stellate cell-derived exosomes MODULATE macrophage inflammatory response. Experimental Cell Research. 112663. PMID 34051242 DOI: 10.1016/j.yexcr.2021.112663  0.746
2020 Attal N, Sullivan MT, Girardi CA, Thompson KJ, McKillop IH. Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression. Translational Oncology. 14: 100975. PMID 33290990 DOI: 10.1016/j.tranon.2020.100975  0.442
2020 Sulzer JK, Motz BM, Pickens RC, Salibi P, McKillop IH, Vrochides D, Martinie JB, Baker EH, Ocuin LM, Iannitti DA. Recurrence patterns following laparscopic ultrasound-guided microwave ablation for colorectal liver metastases Hpb. 22. DOI: 10.1016/J.Hpb.2020.04.611  0.343
2019 Ma HY, Yamamoto G, Xu J, Liu X, Karin D, Kim JY, Alexandrov LB, Koyama Y, Nishio T, Benner C, Heinz S, Rosenthal SB, Liang S, Sun M, Karin G, ... ... Mckillop IH, et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. Journal of Hepatology. PMID 31899206 DOI: 10.1016/J.Jhep.2019.12.016  0.457
2019 Motz B, Pickens R, Sulzer J, Cochran A, McKillop I, Vrochides D, Martinie J, Baker E, Ocuin L, Iannitti D. Local recurrence rates following laparoscopic ultrasound-guided microwave ablation for hepatic metastases of colorectal adenocarcinoma Hpb. 21: S77. DOI: 10.1016/J.Hpb.2019.03.127  0.308
2019 Pickens R, Sulzer J, Lyman W, Cochran A, McKillop I, Vrochides D, Martinie J, Baker E, Ocuin L, Iannitti D. Operative microwave ablation of neuroendocrine liver metastases: a 10-year, single-center review Hpb. 21: S63-S64. DOI: 10.1016/J.Hpb.2019.03.105  0.317
2018 Powell RD, Goodenow DA, Christmas AB, Mckillop IH, Evans SL. Effect of Systemic Triphenylphosphonium on Organ Function and Oxidative Stress. The American Surgeon. 84: 36-42. PMID 29428024 DOI: 10.1177/000313481808400119  0.31
2018 Patetta M, Stello Z, Lee J, Jacobs C, Gersin K, Iannitti D, Mckillop I, Thompson K. Novel role for fatty acid binding protein-4 (FABP4) in hepatocellular carcinoma (HCC) progression Hpb. 20: S352-S353. DOI: 10.1016/J.Hpb.2018.06.2585  0.41
2017 Brandon-Warner E, Benbow JH, Swet JH, Feilen NA, Culberson CR, McKillop IH, deLemos AS, Russo MW, Schrum LW. Adeno-Associated Virus 2 (AAV2)-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Human Gene Therapy. PMID 29281894 DOI: 10.1089/Hum.2017.035  0.756
2017 Thompson KJ, Austin RG, Nazari SS, Gersin KS, Iannitti DA, McKillop IH. Altered fatty acid binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29171144 DOI: 10.1111/Liv.13639  0.435
2017 Thompson KJ, Nazari SS, Jacobs WC, Grahame NJ, McKillop IH. Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury. Alcohol and Alcoholism (Oxford, Oxfordshire). 1-9. PMID 29036399 DOI: 10.1093/Alcalc/Agx063  0.342
2017 Siddiqui IA, Kirks RC, Latouche EL, DeWitt MR, Swet JH, Baker EH, Vrochides D, Iannitti DA, Davalos RV, McKillop IH. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures. Surgical Innovation. 24: 276-283. PMID 28492356 DOI: 10.1177/1553350617692202  0.316
2017 Baker EH, Thompson K, McKillop IH, Cochran A, Kirks R, Vrochides D, Martinie JB, Swan RZ, Iannitti DA. Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients. Journal of Gastrointestinal Oncology. 8: 337-346. PMID 28480072 DOI: 10.21037/Jgo.2016.09.06  0.438
2016 McKillop IH, Schrum LW, Thompson KJ. Role of alcohol in the development and progression of hepatocellular carcinoma. Hepatic Oncology. 3: 29-43. PMID 30191025 DOI: 10.2217/Hep.15.40  0.475
2016 Siddiqui IA, Latouche EL, DeWitt MR, Swet JH, Kirks RC, Baker EH, Iannitti DA, Vrochides D, Davalos RV, McKillop IH. Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 18: 726-34. PMID 27593589 DOI: 10.1016/J.Hpb.2016.06.015  0.309
2016 Siddiqui IA, Kirks RC, Baker EH, Latouche E, Dewitt M, Swet J, Vrochides D, Iannitti DA, Davalos R, Mckillop I. High frequency irreversible electroporation (H-FIRE) as a novel method of targeted cell death. Journal of Clinical Oncology. 34: 277-277. DOI: 10.1200/Jco.2016.34.4_Suppl.277  0.302
2016 Baker E, Thompson K, Cochran A, Vrochides D, Martinie J, Russo M, Mckillop I, Iannitti D, Swan R. Neoadjuvant transarterial chemoembolization prior to microwave ablation of hepatocellular carcinoma: Tumor viability at the time of ablation Hpb. 18: e203-e204. DOI: 10.1016/J.Hpb.2016.02.498  0.391
2016 Baker E, Thompson K, Mckillop I, Cochran A, Russo M, Vrochides D, Martinie J, Iannitti D, Swan R. Operative microwave ablation for hepatocellular carcinoma: Postoperative outcomes, recurrence and survival Hpb. 18: e200. DOI: 10.1016/J.Hpb.2016.02.488  0.343
2016 Siddiqui I, Lorimer P, Baker E, Kirks R, Kyle T, Cochran A, Swan R, Mckillop I, Martinie J, Vrochides D, Iannitti D. Microwave ablation in metastatic neuroendocrine liver lesions: A valuable adjunct to resection Hpb. 18: e192. DOI: 10.1016/J.Hpb.2016.02.466  0.33
2015 Zuckerman V, Sokolov E, Swet JH, Ahrens WA, Showlater V, Iannitti DA, Mckillop IH. Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells. Oncotarget. PMID 26701886 DOI: 10.18632/Oncotarget.6696  0.456
2015 Benbow JH, Thompson KJ, Cope HL, Brandon-Warner E, Culberson CR, Bossi KL, Li T, Russo MW, Gersin KS, McKillop IH, deLemos AS, Schrum LW. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling. The American Journal of Pathology. PMID 26603137 DOI: 10.1016/J.Ajpath.2015.09.015  0.782
2015 Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P, Seitz HK, Mueller S, Mell H, Samuel D, Cohen L, Kharbanda KK, Osna NA, Ganesan M, Thompson KJ, ... McKillop IH, et al. Review: Alcoholic Liver Disease: Clinical and Translational Research. Experimental and Molecular Pathology. PMID 26342547 DOI: 10.1016/J.Yexmp.2015.09.001  0.329
2015 McKillop IH. Alcohol and the brain-liver axis: a further case of mind over matter? Alcoholism, Clinical and Experimental Research. 39: 405-7. PMID 25704362 DOI: 10.1111/Acer.12652  0.321
2015 Thompson KJ, Humphries JR, Niemeyer DJ, Sindram D, McKillop IH. The effect of alcohol on Sirt1 expression and function in animal and human models of hepatocellular carcinoma (HCC). Advances in Experimental Medicine and Biology. 815: 361-73. PMID 25427918 DOI: 10.1007/978-3-319-09614-8_21  0.474
2015 Sindram D, Simo KA, Swan RZ, Razzaque S, Niemeyer DJ, Seshadri RM, Hanna E, McKillop IH, Iannitti DA, Martinie JB. Laparoscopic microwave ablation of human liver tumours using a novel three-dimensional magnetic guidance system. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 17: 87-93. PMID 25231167 DOI: 10.1111/Hpb.12315  0.307
2015 Thompson K, Iannitti DA, Swan RZ, Schrum LW, McKillop IH. SY14-5OBESITY AND ALCOHOL AS INDEPENDENT AND CO-MORBID RISK FACTORS FOR HCC Alcohol and Alcoholism. 50: i17.2-i17. DOI: 10.1093/Alcalc/Agv076.60  0.418
2014 Niemeyer DJ, Simo KA, Iannitti DA, McKillop IH. Ablation therapy for hepatocellular carcinoma: past, present and future perspectives. Hepatic Oncology. 1: 67-79. PMID 30190942 DOI: 10.2217/Hep.13.8  0.463
2014 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A, Thompson KJ, McKillop IH, Kirpich IA, McClain CJ, Bataller R, et al. Alcoholic and non-alcoholic steatohepatitis. Experimental and Molecular Pathology. 97: 492-510. PMID 25217800 DOI: 10.1016/J.Yexmp.2014.09.005  0.379
2014 Seshadri RM, Besur S, Niemeyer DJ, Templin M, McKillop IH, Swan RZ, Martinie JB, Russo MW, Iannitti DA. Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 16: 1102-9. PMID 24964271 DOI: 10.1111/Hpb.12300  0.428
2014 Simo KA, Niemeyer DJ, Hanna EM, Swet JH, Thompson KJ, Sindram D, Iannitti DA, Eheim AL, Sokolov E, Zuckerman V, McKillop IH. Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 16: 534-42. PMID 24750398 DOI: 10.1111/Hpb.12176  0.374
2014 Simo KA, McKillop IH, McMillan MT, Ahrens WA, Walters AL, Thompson KJ, Kuwada TS, Martinie JB, Iannitti DA, Gersin KS, Sindram D. Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery? Obesity Surgery. 24: 15-21. PMID 23934335 DOI: 10.1007/S11695-013-1044-6  0.35
2014 Swet JH, Pacheco HJ, Iannitti DA, El-Ghanam A, McKillop IH. A silica-calcium-phosphate nanocomposite drug delivery system for the treatment of hepatocellular carcinoma: in vivo study. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 102: 190-202. PMID 23913418 DOI: 10.1002/Jbm.B.32995  0.374
2014 Brandon-Warner E, Field C, Culberson C, McKillop I, Schrum L. P626 PROCESSING OF miR17–92 CLUSTER IN HEPATIC STELLATE CELLS PROMOTES HEPATIC FIBROGENESIS Journal of Hepatology. 60: S277. DOI: 10.1016/S0168-8278(14)60788-1  0.746
2014 Thompson K, Nazari S, Sindram D, McKillop I. P295 EXPRESSION OF FATTY ACID BINDING PROTEINS (FABPS) IN A MOUSE MODEL OF OBESITY-DEPENDENT HEPATOCELLULAR CARCINOMA (HCC) Journal of Hepatology. 60: S163-S164. DOI: 10.1016/S0168-8278(14)60457-8  0.401
2013 Thompson KJ, Swan RZ, Walling TL, Iannitti DA, McKillop IH, Sindram D. Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo. Surgical Endoscopy. 27: 2782-91. PMID 23468327 DOI: 10.1007/S00464-013-2808-8  0.442
2013 Sokolov E, Eheim AL, Ahrens WA, Walling TL, Swet JH, McMillan MT, Simo KA, Thompson KJ, Sindram D, McKillop IH. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. The Journal of Surgical Research. 180: 104-13. PMID 23182454 DOI: 10.1016/J.Jss.2012.10.054  0.449
2013 Thompson KJ, Swan RZ, Iannitti DA, McKillop IH, Sindram D. Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model. Surgical Endoscopy. 27: 246-55. PMID 22806512 DOI: 10.1007/S00464-012-2429-7  0.433
2012 Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH. Rodent models of alcoholic liver disease: of mice and men. Alcohol (Fayetteville, N.Y.). 46: 715-25. PMID 22960051 DOI: 10.1016/J.Alcohol.2012.08.004  0.753
2012 Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Letters. 326: 88-95. PMID 22863537 DOI: 10.1016/J.Canlet.2012.07.028  0.772
2012 Vedantham K, Swet JH, McKillop IH, El-Ghannam A. Evaluation of a bioresorbable drug delivery system for the treatment of hepatocellular carcinoma. Journal of Biomedical Materials Research. Part A. 100: 432-40. PMID 22105845 DOI: 10.1002/Jbm.A.33228  0.394
2012 Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcoholism, Clinical and Experimental Research. 36: 641-53. PMID 22017344 DOI: 10.1111/J.1530-0277.2011.01660.X  0.781
2012 Lakner A, Simo K, Hanna E, Schrum L, McKillop I, Sokolov E. 286 ALTERED LYSOPHOSPHATIDIC ACID RECEPTOR EXPRESSION IN LIVER REGENERATION AND HEPATOCELLULAR CARCINOMA (HCC) Journal of Hepatology. 56: S118. DOI: 10.1016/S0168-8278(12)60299-2  0.382
2012 Swet J, Simo K, Pacheco H, Sindram D, Iannitti D, El-Ghannam A, Mckillop I. 108 EVALUATION OF A NOVEL BIOCERAMIC DRUG DELIVERY SYSTEM FOR TREATING HEPATOCELLULAR CARCINOMA (HCC) IN VIVO Journal of Hepatology. 56: S48. DOI: 10.1016/S0168-8278(12)60122-6  0.434
2011 Ellefson WM, Lakner AM, Hamilton A, McKillop IH, Bonkovsky HL, Steuerwald NM, Huet YM, Schrum LW. Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen. Plos One. 6: e29463. PMID 22206017 DOI: 10.1371/Journal.Pone.0029463  0.344
2011 Keller SA, Moore CC, Clemens MG, McKillop IH, Huynh T. Activated protein C restores hepatic microcirculation during sepsis by modulating vasoregulator expression. Shock (Augusta, Ga.). 36: 361-9. PMID 21897335 DOI: 10.1097/Shk.0B013E31822C7380  0.383
2011 Yip-Schneider MT, Doyle CJ, McKillop IH, Wentz SC, Brandon-Warner E, Matos JM, Sandrasegaran K, Saxena R, Hennig ME, Wu H, Waters JA, Klein PJ, Froehlich JC, Schmidt CM. Alcohol induces liver neoplasia in a novel alcohol-preferring rat model. Alcoholism, Clinical and Experimental Research. 35: 2216-25. PMID 21790668 DOI: 10.1111/J.1530-0277.2011.01568.X  0.763
2011 Thompson KJ, Lakner AM, Cross BW, Tsukada S, Rippe RA, McKillop IH, Schrum LW. S-adenosyl-L-methionine inhibits collagen secretion in hepatic stellate cells via increased ubiquitination. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 891-901. PMID 21645221 DOI: 10.1111/J.1478-3231.2011.02512.X  0.405
2011 Thompson KJ, McKillop IH, Schrum LW. Targeting collagen expression in alcoholic liver disease. World Journal of Gastroenterology : Wjg. 17: 2473-81. PMID 21633652 DOI: 10.3748/Wjg.V17.I20.2473  0.429
2011 Sokolov E, Iannitti DA, Schrum LW, McKillop IH. Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma. Cellular Signalling. 23: 1603-10. PMID 21620966 DOI: 10.1016/J.Cellsig.2011.05.012  0.464
2011 Thompson KJ, Lau KN, Johnson S, Martinie JB, Iannitti DA, McKillop IH, Sindram D. Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 13: 225-33. PMID 21418127 DOI: 10.1111/J.1477-2574.2010.00259.X  0.464
2011 Sindram D, Swan RZ, Lau KN, McKillop IH, Iannitti DA, Martinie JB. Real-time three-dimensional guided ultrasound targeting system for microwave ablation of liver tumours: a human pilot study. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 13: 185-91. PMID 21309936 DOI: 10.1111/J.1477-2574.2010.00269.X  0.346
2011 Lakner AM, Walling TL, McKillop IH, Schrum LW. Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 42-51. PMID 20958918 DOI: 10.1111/J.1478-3231.2010.02356.X  0.428
2011 Bleich S, Heberlein A, Hillemacher T, Fernandez-Sola J, Brandon-Warner E, McKillop IH. S19 * ESBRA/EASL JOINT SYMPOSIUM: CURRENT THERAPY OF PATIENTS WITH ALCOHOLIC LIVER DISEASE * S19.1 * THERAPY OF ALCOHOL ADDICTION Alcohol and Alcoholism. 46: i17-i18. DOI: 10.1093/alcalc/agr109  0.716
2010 Huynh T, Nguyen N, Keller S, Moore C, Shin MC, McKillop IH. Reducing leukocyte trafficking preserves hepatic function after sepsis. The Journal of Trauma. 69: 360-7. PMID 20699745 DOI: 10.1097/Ta.0B013E3181E65133  0.353
2010 Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Letters. 291: 120-9. PMID 19900758 DOI: 10.1016/J.Canlet.2009.10.004  0.775
2009 Padma S, Smeltz AM, Banks PM, Iannitti DA, McKillop IH. Altered aquaporin 9 expression and localization in human hepatocellular carcinoma. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 11: 66-74. PMID 19590626 DOI: 10.1111/J.1477-2574.2008.00014.X  0.453
2009 McKillop IH, Schrum LW. Role of alcohol in liver carcinogenesis. Seminars in Liver Disease. 29: 222-32. PMID 19387921 DOI: 10.1055/S-0029-1214377  0.413
2009 Hennig M, Yip-Schneider MT, Klein P, Wentz S, Matos JM, Doyle C, Choi J, Wu H, O'Mara A, Menze A, Noble S, McKillop IH, Schmidt CM. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. The Journal of Surgical Research. 154: 187-95. PMID 19321179 DOI: 10.1016/J.Jss.2008.11.836  0.419
2008 Zimmers TA, Jin X, Gutierrez JC, Acosta C, McKillop IH, Pierce RH, Koniaris LG. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. Journal of Cancer Research and Clinical Oncology. 134: 753-9. PMID 18210153 DOI: 10.1007/S00432-007-0336-4  0.423
2008 Karaa A, Thompson KJ, McKillop IH, Clemens MG, Schrum LW. S-adenosyl-L-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model. Shock (Augusta, Ga.). 30: 197-205. PMID 18180699 DOI: 10.1097/Shk.0B013E318160F417  0.395
2008 Moran DM, Mattocks MA, Cahill PA, Koniaris LG, McKillop IH. Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. The Journal of Surgical Research. 147: 23-33. PMID 17574577 DOI: 10.1016/J.Jss.2007.04.022  0.741
2007 Jablonski EM, Mattocks MA, Sokolov E, Koniaris LG, Hughes FM, Fausto N, Pierce RH, McKillop IH. Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Letters. 250: 36-46. PMID 17084522 DOI: 10.1016/J.Canlet.2006.09.013  0.72
2006 Moran DM, Koniaris LG, Jablonski EM, Cahill PA, Halberstadt CR, McKillop IH. Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transplantation. 15: 785-98. PMID 17269449 DOI: 10.3727/000000006783981477  0.782
2006 McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. The Journal of Surgical Research. 136: 125-35. PMID 17023002 DOI: 10.1016/J.Jss.2006.04.013  0.466
2006 Kovach SJ, Price JA, Shaw CM, Theodorakis NG, McKillop IH. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma. Journal of Cellular Physiology. 206: 411-9. PMID 16110470 DOI: 10.1002/Jcp.20474  0.483
2006 Hennig M, Klein P, Matos J, Norris A, Noble S, Doyle C, McKillop I, Wiebke E, Schmidt C. Ethanol-TGF-α-Mek growth signaling may promote alcohol associated human hepatocellular carcinoma Journal of Surgical Research. 130: 263. DOI: 10.1016/J.Jss.2005.11.290  0.38
2005 McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol (Fayetteville, N.Y.). 35: 195-203. PMID 16054981 DOI: 10.1016/J.Alcohol.2005.04.004  0.434
2005 Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 445-57. PMID 15780071 DOI: 10.1111/J.1478-3231.2005.01083.X  0.473
2003 Zimmers TA, Pierce RH, McKillop IH, Koniaris LG. Resolving the role of IL-6 in liver regeneration. Hepatology (Baltimore, Md.). 38: 1590-1; author reply. PMID 14647070 DOI: 10.1016/J.Hep.2003.09.021  0.342
2003 Zimmers TA, McKillop IH, Pierce RH, Yoo JY, Koniaris LG. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology (Baltimore, Md.). 38: 326-34. PMID 12883476 DOI: 10.1053/Jhep.2003.50318  0.387
2003 PRICE J, KOVACH S, THEODORAKIS N, MCKILLOP I. 851 Stimulatory G-protein (GS) inhibition of hepatocellular carcinoma (HCC) growth Hepatology. 38: 571-571. DOI: 10.1016/S0270-9139(03)80893-5  0.419
2003 MORAN D, ZIMMERS T, KONIARIS L, MCKILLOP I. 850 Inhibition of hepatocellular carcinoma (HCC) cell growth by interleukin-6 Hepatology. 38: 570-571. DOI: 10.1016/S0270-9139(03)80892-3  0.451
2002 Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology (Baltimore, Md.). 36: 1089-97. PMID 12395318 DOI: 10.1053/Jhep.2002.36158  0.45
2002 Price J, Kovach S, Sitzmann J, Mckillop I. Insulin-like growth factor-I (IGF-I) stimulates C-fos and C-jun expression but not complete mitogenesis in experimental hepatocellular carcinoma (HCC) Journal of Hepatology. 36: 217. DOI: 10.1016/S0168-8278(02)80776-0  0.369
2002 Kovach S, Price J, Thodorakis N, Sitzmann J, McKillop I. Altered expression and function of cAMP responsive elements (CRE'S) in cell growth and progression in experimental hepatocellular carcinoma HCC Journal of Hepatology. 36: 216-217. DOI: 10.1016/S0168-8278(02)80774-7  0.441
2002 Zimmers T, McKillop I, Pierce R, Yoo J, Murtha-Riel P, Koniaris L. Massive liver growth induced by interleukin-6 overexpression in mice Journal of Hepatology. 36: 81. DOI: 10.1016/S0168-8278(02)80278-1  0.339
2001 Kovach SJ, Sitzmann JV, McKillop IH. Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro European Journal of Gastroenterology and Hepatology. 13: 1209-1216. PMID 11711778 DOI: 10.1097/00042737-200110000-00014  0.453
2000 Kovach S, McKillop I, Sitzmann J. Ethanol metabolites enhance Gi-protein dependent mitogenesis in hepatocellular carcinoma (HCC) Journal of the American College of Surgeons. 191: S24. DOI: 10.1016/S1072-7515(00)00441-5  0.436
1999 Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro European Journal of Gastroenterology and Hepatology. 11: 1393-1399. PMID 10654800 DOI: 10.1097/00042737-199912000-00009  0.426
1999 McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV. Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro European Journal of Gastroenterology and Hepatology. 11: 761-768. PMID 10445797 DOI: 10.1097/00042737-199907000-00014  0.39
1999 Cappadona C, Redmond EM, Theodorakis NG, McKillop IH, Hendrickson R, Chhabra A, Sitzmann JV, Cahill PA. Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro. Experimental Cell Research. 250: 174-86. PMID 10388531 DOI: 10.1006/Excr.1999.4502  0.327
1999 McKillop IH, Vyas N, Max Schmidt C, Cahill PA, Sitzmann JV. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma Hepatology. 29: 412-420. PMID 9918917 DOI: 10.1002/Hep.510290218  0.401
1999 McKillop IH, Max Schmidt C, Cahill PA, Sitzmann JV. Altered Gq/G11 guanine nucleotide regulatory protein expression in a rat model of hepatocellular carcinoma: Role in mitogenesis Hepatology. 29: 371-378. PMID 9918912 DOI: 10.1002/Hep.510290201  0.469
1998 Hendrickson RJ, Cahill PA, McKillop IH, Sitzmann JV, Redmond EM. Ethanol inhibits mitogen activated protein kinase activity and growth of vascular smooth muscle cells in vitro. European Journal of Pharmacology. 362: 251-9. PMID 9874178 DOI: 10.1016/S0014-2999(98)00771-7  0.305
1998 McKillop IH, Wu Y, Cahill PA, Sitzmann JV. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma Journal of Cellular Physiology. 175: 295-304. PMID 9572474 DOI: 10.1002/(Sici)1097-4652(199806)175:3<295::Aid-Jcp7>3.0.Co;2-J  0.474
1998 Schmidt C, McKillop I, Cahill P, Sitzmann J. Inhibitory guanine nucleotide proteins regulate human hepatocellular carcinoma growth via a MAPK pathway Gastroenterology. 114: A1337. DOI: 10.1016/S0016-5085(98)85427-9  0.407
1997 McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma Hepatology. 26: 1484-1491. PMID 9397988 DOI: 10.1002/Hep.510260615  0.379
1997 Schmidt CM, Mckillop IH, Cahill PA, Sitzmann JV. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma Hepatology. 26: 1189-1194. PMID 9362361 DOI: 10.1002/Hep.510260516  0.388
1997 Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK expression and activity in primary human hepatocellular carcinoma Biochemical and Biophysical Research Communications. 236: 54-58. PMID 9223425 DOI: 10.1006/Bbrc.1997.6840  0.399
Show low-probability matches.